Literature DB >> 8394809

DNA-sequence binding preference of the GC-selective ligand mithramycin. Deoxyribonuclease-I/deoxyribonuclease-II and hydroxy-radical footprinting at CCCG, CCGC, CGGC, GCCC and GGGG flanked by (AT)n and An.Tn.

M L Carpenter1, J N Marks, K R Fox.   

Abstract

We have used hydroxy-radical and deoxyribonuclease-I footprinting to probe the interaction of mithramycin with DNA fragments containing the sequences (AT)10X(AT)10 (X = CCCG, CCGC or CGGC) and A14GCCCT15. As expected the drug produces clear footprints located around the central four GC base pairs. The exact position of the footprint is different for the four sequences; the footprint with CCCG is displayed by two base pairs in the 5' direction relative to GCCC. These variations are explained by suggesting that mithramycin avoids the dinucleotide CG and binds better to GG/CC than GC. Although there is little change in deoxyribonuclease-I cleavage of the surrounding blocks of (AT)n, cleavage by deoxyribonuclease II is markedly enhanced and certain thymines on the 5' side of the ligand-binding site become hyperreactive to hydroxy-radical attack. Adjacent regions of An.Tn show enhanced rates of deoxyribonuclease-I cleavage in the presence of the antibiotic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394809     DOI: 10.1111/j.1432-1033.1993.tb18066.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter.

Authors:  M Rafiq Islam; Sanjeev Puri; Marianna Rodova; Brenda S Magenheimer; Robin L Maser; James P Calvet
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-15

2.  Dimerization and DNA recognition rules of mithramycin and its analogues.

Authors:  Stevi Weidenbach; Caixia Hou; Jhong-Min Chen; Oleg V Tsodikov; Jürgen Rohr
Journal:  J Inorg Biochem       Date:  2015-12-18       Impact factor: 4.155

3.  Dissociation of the AT-specific bifunctional intercalator [N-MeCys3,N-MeCys7]TANDEM from TpA sites in DNA.

Authors:  M C Fletcher; R K Olsen; K R Fox
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

4.  Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions.

Authors:  Alessia Finotti; Nicoletta Bianchi; Enrica Fabbri; Monica Borgatti; Giulia Breveglieri; Jessica Gasparello; Roberto Gambari
Journal:  Pharmacol Res       Date:  2014-12-03       Impact factor: 7.658

5.  Discrimination between G/C Binding Sites by Olivomycin A Is Determined by Kinetics of the Drug-DNA Interaction.

Authors:  Artemy D Beniaminov; Galina V Chashchina; Mikhail A Livshits; Olga I Kechko; Vladimir A Mitkevich; Olga K Mamaeva; Anna N Tevyashova; Alexander A Shtil; Anna K Shchyolkina; Dmitry N Kaluzhny
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

6.  Differential Impact of Random GC Tetrad Binding and Chromatin Events on Transcriptional Inhibition by Olivomycin A.

Authors:  Alexandra K Isagulieva; Dmitry N Kaluzhny; Artemy D Beniaminov; Nataliya V Soshnikova; Alexander A Shtil
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

Review 7.  Chromatin as a target for the DNA-binding anticancer drugs.

Authors:  Parijat Majumder; Suman K Pradhan; Pukhrambam Grihanjali Devi; Sudipta Pal; Dipak Dasgupta
Journal:  Subcell Biochem       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.